MR编号 | SE/H/0940/002 |
---|
药品名称 | Quatriga Low Osmo Peripheral |
---|
活性成分 | - Alanine 3.5 g/l
- Arginine 3.0 g/l
- Calcium chloride 0.14 g/l
- fish oil, rich in omega 3-acids 5.3 g/l
- Glucose 68.0 g/l
- Glycine 2.8 g/l
- Histidine 0.75 g/l
- Isoleucine 1.3 g/l
- Leucine 1.9 g/l
- Lysine acetate 1.7 g/l
- Magnesium sulfate 0.3 g/l
- medium-chain triglycerides 11.0 g/l
- Methionine 1.1 g/l
- OLIVE OIL 8.8 g/l
- Phenylalanine 1.3 g/l
- Potassium chloride 1.1 g/l
- Proline 2.8 g/l
- Serine 1.6 g/l
- Sodium acetate 0.85 g/l
- SODIUM GLYCEROPHOSPHATE 1.0 g/l
- SOYBEAN OIL 11.0 g/l
- Taurine 0.25 g/l
- Threonine 1.1 g/l
- Tryptophan 0.5 g/l
- Tyrosine 0.1 g/l
- Valine 1.6 g/l
- Zinc sulfate 3.2 mg/l
|
---|
剂型 | Emulsion for infusion |
---|
上市许可持有人 | Fresenius Kabi AB, Sweden |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | |
---|
许可日期 | 2021/02/16 |
---|
最近更新日期 | 2025/02/07 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Line Extension
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|